Investigation on Investor Claims Continues as Faruqi & Faruqi, LLP Looks Into Amylyx Pharmaceuticals Inc.
Mar 20, 2024
AMLX Equities
Investor Notice: Deadline Approaching in Amylyx Pharmaceuticals Class Action Lawsuit
Feb 28, 2024
Investors with Significant Losses in AMLX Have a Chance to Lead Lawsuit, Announces Law Firm
Feb 19, 2024
Rosen Law Firm Advocates for Amylyx Pharmaceuticals Investors Ahead of Key Litigation Deadline
Feb 17, 2024
Class Action Lawsuit Initiated Against Amylyx Pharmaceuticals, Prompting Investor Alert by Bragar Eagel & Squire, P.C.
Feb 11, 2024
Molina Healthcare's Q4 Earnings: Impact of Medicaid Decline and Rising Medical Costs
Feb 2, 2024
Bragar Eagel & Squire, P.C. Investigates Amylyx Pharmaceuticals on Behalf of Stockholders, Urges Investors to Contact the Firm
Jan 8, 2024